-
1
-
-
0003403474
-
-
Berlin, Heidelberg, New York: Springer Verlag
-
Becker N, Wahrenburg J. Krebsatlas der Bundesrepublik Deutschland 1981-1990, 3ed. Berlin, Heidelberg, New York: Springer Verlag, 1997: 366pp.
-
(1997)
Krebsatlas der Bundesrepublik Deutschland 1981-1990, 3ed.
-
-
Becker, N.1
Wahrenburg, J.2
-
2
-
-
0345432526
-
-
National Cancer Institute of the USA, Cancer Mortalitiy in the U.S., 1950-1977, 164-73.
-
(1950)
Cancer Mortalitiy in the U.S.
, pp. 164-173
-
-
-
4
-
-
23544454009
-
-
Berlin, Wiesbaden: Ullstein Mosby GmbH
-
Hayes DF, editor. Brustkrebs. 1ed. Berlin, Wiesbaden: Ullstein Mosby GmbH, 1995.
-
(1995)
Brustkrebs. 1ed.
-
-
Hayes, D.F.1
-
7
-
-
0344570397
-
-
Marburg, Frankfurt: Behringwerke AG
-
Lammerz R, Dati F, Feller AC, Schnorr G. Tumordiagnostik: Tumormarker bei malignen Erkrankungen, 1ed. Marburg, Frankfurt: Behringwerke AG, 1988.
-
(1988)
Tumordiagnostik: Tumormarker bei Malignen Erkrankungen, 1ed.
-
-
Lammerz, R.1
Dati, F.2
Feller, A.C.3
Schnorr, G.4
-
8
-
-
0024493039
-
Der Nachweis und die Bedeutung des Tissue-Polypeptid-Antigen (TPA) bei Mammakarzinompatientinnen
-
Meißner J, Kasch R. Der Nachweis und die Bedeutung des Tissue-Polypeptid-Antigen (TPA) bei Mammakarzinompatientinnen. Zentrbl Gynäkol 1989; 111:29-32.
-
(1989)
Zentrbl Gynäkol
, vol.111
, pp. 29-32
-
-
Meißner, J.1
Kasch, R.2
-
9
-
-
0028324423
-
B. Early diagnosis of breast cancer dissemination by tumor markers follow-up and method of prediction
-
Nekulova M, Simickova M, Pecen L, Eben K, Vermousek I, Stratil P, et al. B. Early diagnosis of breast cancer dissemination by tumor markers follow-up and method of prediction. Neoplasma 1994; 41:113-8.
-
(1994)
Neoplasma
, vol.41
, pp. 113-118
-
-
Nekulova, M.1
Simickova, M.2
Pecen, L.3
Eben, K.4
Vermousek, I.5
Stratil, P.6
-
10
-
-
0027480715
-
Tissue polypeptide antigen in breast cancer cytosol: A new effective prognostic indicator
-
Gion M, Mione R, Pappagallo GL, Gatti C, Nascimben O, Brandes A, et at. Tissue polypeptide antigen in breast cancer cytosol: a new effective prognostic indicator. Eur J Cancer 1993; 29A:66-9.
-
(1993)
Eur J Cancer
, vol.29 A
, pp. 66-69
-
-
Gion, M.1
Mione, R.2
Pappagallo, G.L.3
Gatti, C.4
Nascimben, O.5
Brandes, A.6
-
11
-
-
0025676266
-
Tissue polypeptide antigen in tumor cytosol: A new prognostic indicator in primary breast cancer
-
Gion M, Mione R, Gatti C, Dittadi R, Leon A, Castiglioni C, Nascimben O, et al. Tissue polypeptide antigen in tumor cytosol: a new prognostic indicator in primary breast cancer. Breast Cancer Res Tr 1990; 17:15-21.
-
(1990)
Breast Cancer Res Tr
, vol.17
, pp. 15-21
-
-
Gion, M.1
Mione, R.2
Gatti, C.3
Dittadi, R.4
Leon, A.5
Castiglioni, C.6
Nascimben, O.7
-
12
-
-
0025896924
-
Tissue polypeptide antigen activity in cerebrospinal fluid: A marker of central nervous system metastases of breast cancer
-
Bach F, Soletormos G, Dombernowsky P. Tissue polypeptide antigen activity in cerebrospinal fluid: a marker of central nervous system metastases of breast cancer. J Natl Cancer Inst 1991; 83:779-84.
-
(1991)
J Natl Cancer Inst
, vol.83
, pp. 779-784
-
-
Bach, F.1
Soletormos, G.2
Dombernowsky, P.3
-
13
-
-
0024523057
-
Circulating CA 15-3 antigen levels in non-mammary malignancies
-
Colomer R, Ruibal A, Genolla J, Salvador L. Circulating CA 15-3 antigen levels in non-mammary malignancies. Br J Cancer 1989; 59:283-6.
-
(1989)
Br J Cancer
, vol.59
, pp. 283-286
-
-
Colomer, R.1
Ruibal, A.2
Genolla, J.3
Salvador, L.4
-
14
-
-
0028076310
-
Clinical profile of a new monoclonal antibody-based immunoassay for tissue polypeptide antigen
-
Correale M, Arnberg H, Blockx P, Bombardier E, Castelli M, Encabo G, et al. Clinical profile of a new monoclonal antibody-based immunoassay for tissue polypeptide antigen, Int J Biol Markers 1994; 9:231-8.
-
(1994)
Int J Biol Markers
, vol.9
, pp. 231-238
-
-
Correale, M.1
Arnberg, H.2
Blockx, P.3
Bombardier, E.4
Castelli, M.5
Encabo, G.6
-
15
-
-
0026576639
-
CA 19-9, CA 125, carcinoembryonic antigen, and tissue polypeptide antigen in differentiating ovarian cancer from benign tumors
-
Inoue M, Fujita M, Nakazawa A, Ogawa H, Tanizawa O. Sialyl-TN, et al. CA 19-9, CA 125, carcinoembryonic antigen, and tissue polypeptide antigen in differentiating ovarian cancer from benign tumors. Obstet Gynecol 1992; 79: 434-40.
-
(1992)
Obstet Gynecol
, vol.79
, pp. 434-440
-
-
Inoue, M.1
Fujita, M.2
Nakazawa, A.3
Ogawa, H.4
Tanizawa, O.5
Sialyl, T.N.6
-
17
-
-
0024351085
-
Erste Erfahrungen mit CA 15-3-Bestimmungen im Serum von Patientinnen mit Mammakarzinom
-
Bartel U, Johannsen B, Reiß H, Elling D. Erste Erfahrungen mit CA 15-3-Bestimmungen im Serum von Patientinnen mit Mammakarzinom. Zentrbl Gynäkol 1989; 111:1417-24.
-
(1989)
Zentrbl Gynäkol
, vol.111
, pp. 1417-1424
-
-
Bartel, U.1
Johannsen, B.2
Reiß, H.3
Elling, D.4
-
20
-
-
0020063749
-
Carcinoembryonic antigen as a monitor of recurrent breast cancer
-
Lee Y. Carcinoembryonic antigen as a monitor of recurrent breast cancer. J Surg Oncol 1982; 20:109.
-
(1982)
J Surg Oncol
, vol.20
, pp. 109
-
-
Lee, Y.1
-
21
-
-
0030889321
-
Serum tumour markers CEA, AFP, CA 15-3, TPS and Neu in diagnosis of breast cancer
-
Eskelinen M, Kataja V, Hämäläinen E, Kosma V-M, Penttila I, Alhava E. Serum tumour markers CEA, AFP, CA 15-3, TPS and Neu in diagnosis of breast cancer. Anticancer Research 1997; 17:1231-4.
-
(1997)
Anticancer Research
, vol.17
, pp. 1231-1234
-
-
Eskelinen, M.1
Kataja, V.2
Hämäläinen, E.3
Kosma, V.-M.4
Penttila, I.5
Alhava, E.6
-
22
-
-
0029831450
-
Clinical value of CA 15-3, mucine-like carcinoma-associated antigen, tumor polypeptide antigen and carcinembryonic antigen in monitoring early breast cancer patients
-
Pectasides D, Pavlidis N, Gogou L, Antoniou F, Nicolaides C, Tsikalakis D, et al. Clinical value of CA 15-3, mucine-like carcinoma-associated antigen, tumor polypeptide antigen and carcinembryonic antigen in monitoring early breast cancer patients. Am J Oncol (CCT) 1996; 19:459-64.
-
(1996)
Am J Oncol (CCT)
, vol.19
, pp. 459-464
-
-
Pectasides, D.1
Pavlidis, N.2
Gogou, L.3
Antoniou, F.4
Nicolaides, C.5
Tsikalakis, D.6
-
23
-
-
0028177899
-
Clinical value of serum tumour markers TPA, TPS, TAG 12, CA 15-3 and MCA in breast cancer diagnosis; results from prospective study
-
Eskelinen M, Hippeläinen M, Kettunen J, Salmela E, Pentilla I, Alhava E. Clinical value of serum tumour markers TPA, TPS, TAG 12, CA 15-3 and MCA in breast cancer diagnosis; results from prospective study. Anticancer Res 1994; 14:699-704.
-
(1994)
Anticancer Res
, vol.14
, pp. 699-704
-
-
Eskelinen, M.1
Hippeläinen, M.2
Kettunen, J.3
Salmela, E.4
Pentilla, I.5
Alhava, E.6
-
24
-
-
0030034152
-
Value of Ca 15.3 and comparison with CEa and TPA: A study of specificity in disease-free follow-up patients and sensitivity in patients at diagnosis of the first metastasis
-
Vizcarra E, Liuch A, Cibrian R, Jarque F, Alberola V, Belloch V, et al. Value of CA 15.3 and comparison with CEA and TPA: a study of specificity in disease-free follow-up patients and sensitivity in patients at diagnosis of the first metastasis. Breast Cancer Res Tr 1996; 37:209-16.
-
(1996)
Breast Cancer Res Tr
, vol.37
, pp. 209-216
-
-
Vizcarra, E.1
Liuch, A.2
Cibrian, R.3
Jarque, F.4
Alberola, V.5
Belloch, V.6
-
26
-
-
0025032720
-
Is TPA still a useful tumor marker in breast cancer -comparison with Ca 15-3 and MCA
-
Gion M. Is TPA still a useful tumor marker in breast cancer -comparison with CA 15-3 and MCA. Tumori 1990; 76:360.
-
(1990)
Tumori
, vol.76
, pp. 360
-
-
Gion, M.1
-
27
-
-
0025515334
-
CA 15-3 associated with CEA and TPA in follow-up of breast carcinoma
-
Maffei S, Rudoni M, Antonini G, Sacchetti G, Krengli M. CA 15-3 associated with CEA and TPA in follow-up of breast carcinoma. Minerva Med 1990; 81:759.
-
(1990)
Minerva Med
, vol.81
, pp. 759
-
-
Maffei, S.1
Rudoni, M.2
Antonini, G.3
Sacchetti, G.4
Krengli, M.5
-
28
-
-
0025901051
-
Evaluation of TPA in the post-operation follow-up of breast cancer patients
-
Nicolini A, Colombini C. Evaluation of TPA in the post-operation follow-up of breast cancer patients. Br J Cancer 1991; 64:154.
-
(1991)
Br J Cancer
, vol.64
, pp. 154
-
-
Nicolini, A.1
Colombini, C.2
|